In pharmaceutical manufacturing, where precision and compliance are foundational, the processes that support data movement and equipment operation often remain complex and fragmented. The sector is undergoing rapid transformation driven by advancing technology, rising expectations for real-time, data-driven decision-making, and growing pressure to improve efficiency across operations. At the same time, healthcare costs have surpassed $5 trillion in the United States and are increasing at approximately 8% annually, reinforcing the need for more streamlined and reliable systems that can support both compliance and performance.
According to Ben Davis, CEO of Phizzle, the challenge is not rooted in a lack of innovation within the industry, but in the way systems interact. He explains that pharmaceutical environments frequently rely on multiple instruments produced by different manufacturers, each operating with its own interface, communication protocol, and data format. When these systems are brought together, the process of transferring and validating data often becomes dependent on a mix of manual workflows and disconnected tools.
